Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response.

Salvagno C, Ciampricotti M, Tuit S, Hau CS, van Weverwijk A, Coffelt SB, Kersten K, Vrijland K, Kos K, Ulas T, Song JY, Ooi CH, Rüttinger D, Cassier PA, Jonkers J, Schultze JL, Ries CH, de Visser KE.

Nat Cell Biol. 2019 Apr;21(4):511-521. doi: 10.1038/s41556-019-0298-1. Epub 2019 Mar 18.

PMID:
30886344
2.

Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages.

Kersten K, Coffelt SB, Hoogstraat M, Verstegen NJM, Vrijland K, Ciampricotti M, Doornebal CW, Hau CS, Wellenstein MD, Salvagno C, Doshi P, Lips EH, Wessels LFA, de Visser KE.

Oncoimmunology. 2017 Jun 19;6(8):e1334744. doi: 10.1080/2162402X.2017.1334744. eCollection 2017.

3.

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.

Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJM, Ciampricotti M, Hawinkels LJAC, Jonkers J, de Visser KE.

Nature. 2015 Jun 18;522(7556):345-348. doi: 10.1038/nature14282. Epub 2015 Mar 30.

4.

Morphine does not facilitate breast cancer progression in two preclinical mouse models for human invasive lobular and HER2⁺ breast cancer.

Doornebal CW, Vrijland K, Hau CS, Coffelt SB, Ciampricotti M, Jonkers J, de Visser KE, Hollmann MW.

Pain. 2015 Aug;156(8):1424-32. doi: 10.1097/j.pain.0000000000000136.

PMID:
25734987
5.

A preclinical mouse model of invasive lobular breast cancer metastasis.

Doornebal CW, Klarenbeek S, Braumuller TM, Klijn CN, Ciampricotti M, Hau CS, Hollmann MW, Jonkers J, de Visser KE.

Cancer Res. 2013 Jan 1;73(1):353-63. doi: 10.1158/0008-5472.CAN-11-4208. Epub 2012 Nov 14.

6.

Developmental stage-specific contribution of LGR5(+) cells to basal and luminal epithelial lineages in the postnatal mammary gland.

de Visser KE, Ciampricotti M, Michalak EM, Tan DW, Speksnijder EN, Hau CS, Clevers H, Barker N, Jonkers J.

J Pathol. 2012 Nov;228(3):300-9. doi: 10.1002/path.4096.

PMID:
22926799
7.

Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system.

Ciampricotti M, Hau CS, Doornebal CW, Jonkers J, de Visser KE.

Nat Med. 2012 Mar 6;18(3):344-6; author reply 346. doi: 10.1038/nm.2652. No abstract available.

PMID:
22395693
8.

Bmp signaling exerts opposite effects on cardiac differentiation.

de Pater E, Ciampricotti M, Priller F, Veerkamp J, Strate I, Smith K, Lagendijk AK, Schilling TF, Herzog W, Abdelilah-Seyfried S, Hammerschmidt M, Bakkers J.

Circ Res. 2012 Feb 17;110(4):578-87. doi: 10.1161/CIRCRESAHA.111.261172. Epub 2012 Jan 12.

9.

Development of metastatic HER2(+) breast cancer is independent of the adaptive immune system.

Ciampricotti M, Vrijland K, Hau CS, Pemovska T, Doornebal CW, Speksnijder EN, Wartha K, Jonkers J, de Visser KE.

J Pathol. 2011 May;224(1):56-66. doi: 10.1002/path.2837. Epub 2011 Jan 17.

PMID:
21480230
10.

A tissue reconstitution model to study cancer cell-intrinsic and -extrinsic factors in mammary tumourigenesis.

Evers B, Speksnijder EN, Schut E, Ciampricotti M, Smalley MJ, Derksen PW, Jonkers J, de Visser KE.

J Pathol. 2010 Jan;220(1):34-44. doi: 10.1002/path.2655.

PMID:
19927317

Supplemental Content

Loading ...
Support Center